Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dlk1 in normal and abnormal hematopoiesis.

S Sakajiri1, J O'kelly, D Yin

  • 1Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA, Los Angeles, CA 90048, USA.

Leukemia
|June 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developmental Nutrition Affects the Structural Integrity of a Sexually Selected Weapon.

Integrative and comparative biology·2021
Same author

Adipose-derived regenerative cells and fat grafting for treating breast cancer-related lymphedema: Lymphoscintigraphic evaluation with 1 year of follow-up.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2018
Same author

Experimental manipulation reveals a trade-off between weapons and testes.

Journal of evolutionary biology·2017
Same author

The tale of the shrinking weapon: seasonal changes in nutrition affect weapon size and sexual dimorphism, but not contemporary evolution.

Journal of evolutionary biology·2016
Same author

Scaling law for electrocaloric temperature change in antiferroelectrics.

Scientific reports·2016
Same author

How neuroscience relates to hearing aid amplification.

International journal of otolaryngology·2014
Same journal

Single-cell architecture of purinergic signaling in human cord blood hematopoietic stem and progenitor cells.

Leukemia·2026
Same journal

Feasibility and safety of rapid glofitamab ramp-up.

Leukemia·2026
Same journal

Single-cell DNA methylation analysis uncovers epigenetic pathways in the transformation of MDS to AML.

Leukemia·2026
Same journal

PD-L2 is associated with lineage-related transcriptional programs distinct from PD-L1 in primary mediastinal large B-cell lymphoma.

Leukemia·2026
Same journal

Lineage-restricted dependency on an oncofetal SNHG29-IGF2BP1 RNA axis in acute megakaryoblastic leukemia.

Leukemia·2026
Same journal

Selective targeting of RSK signaling with PMD-026 suppresses FLT3-activated acute myeloid leukemia while sparing normal hematopoiesis.

Leukemia·2026
See all related articles

Dlk1 (Pref-1) protein is overexpressed in myelodysplastic syndromes and certain leukemias. This protein is crucial for megakaryocyte and B-cell development, impacting hematopoiesis.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Dlk1 (Pref-1) is an epidermal growth factor-like protein.
  • It is homologous to Notch/Delta/Serrate family proteins.
  • Dlk1 functions as both a transmembrane and secreted protein.

Purpose of the Study:

  • To investigate Dlk1 mRNA and protein expression in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
  • To explore the role of Dlk1 in megakaryocytic differentiation and hematopoiesis.
  • To assess the association of Dlk1 with specific hematological malignancies and conditions.

Main Methods:

  • Real-time RT-PCR to quantify Dlk1 mRNA levels in patient samples and cell lines.
  • Analysis of Dlk1 serum levels in patients with myelodysplastic syndromes and essential thrombocythemia.

Related Experiment Videos

  • Functional studies involving forced expression of Dlk1 in cell lines.
  • Hematopoietic analysis of Dlk1 knockout mice.

    • Main Results:

    • Dlk1 mRNA was elevated in CD34(+) cells from MDS patients and in bone marrow cells from MDS, AML M6, and AML M7 patients.
    • High Dlk1 mRNA expression was observed in erythroleukemia and megakaryocytic leukemia cell lines.
    • Dlk1 mRNA levels increased during megakaryocytic differentiation of CMK cells and normal hematopoietic stem cells.
    • Elevated serum Dlk1 levels were found in patients with RA and essential thrombocythemia.
    • Forced Dlk1 expression enhanced K562 cell proliferation.
    • Dlk1 knockout mice showed impaired granulocyte, megakaryocyte, and B-cell growth, and reduced splenic B-cell generation.

    Conclusions:

    • Dlk1 is overexpressed in specific subtypes of MDS (RA, RAEB) and AML (M6, M7).
    • Dlk1 plays a role in megakaryocyte and B-cell development.
    • Dlk1 contributes to granulocyte, megakaryocyte, and B-cell clonogenic growth.